Blocking Rac1 protein may prevent nerve damage in hATTR-PN: Lab study

Feb 26, 2026

New AL-ISS Model Validated for Prognosis in AL Amyloidosis

Read more

Feb 19, 2026

Mixed primary progressive aphasia and alcohol use disorder: a case of detailed clinical phenotyping outperforming molecular imaging

Read more

Feb 19, 2026

Attruby slows disease progression across ATTR-CM subgroups: Trial data

Read more

Feb 18, 2026

Sex-specific early cognitive changes are linked to global and pathway-specific genetic risk for Alzheimer's disease in at-risk individuals

Read more

Feb 17, 2026

Amyloidosis in Carpal Tunnel Syndrome and 1-Year Cardiovascular and Renal Outcomes: A Propensity Score-Matched Cohort Study

Read more

Feb 16, 2026

Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohort

Read more

Feb 12, 2026

Hologic Gains FDA Clearance for Aptima® HPV Assay as Primary Screening Tool; ZOLL Zenix Monitor/Defibrillator Achieves MDR Approval; Labcorp Unveils FDA-Cleared Blood Test for Alzheimer’s Screening; P&F SecureD EU MDR CE Mark Approval for the TricValve® S

Read more

Feb 06, 2026

Could a Rare Heart Condition Be Hidden behind Heart Failure Diagnoses? ATTR-CM Emerges as Underrecognized Threat

Read more

Feb 02, 2026

New Guidelines Aim to Improve AL Amyloidosis Diagnosis

Read more

Feb 02, 2026

Nuclear imaging in transthyretin amyloid cardiomyopathy

Read more

Subscribe to